RxDoctor Payments Data

Yuelin Xu, MD

Procedural Dermatology · Lansing, MINPI 1669421848

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,891 of the $5,790 with a category attached, or 84.5%. It is spread thinly across 24 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,677 and has fallen 61.8% since, to $641 in 2025.

$5,790in general payments, 2019–2025

Across 300 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$861
  • Almirall LLC$825
  • AbbVie$594
  • UCB, Inc.$438
  • Galderma Laboratories, L.p.$286
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$80014%
  • Food & beverage$4,89184%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$535,538
Medicare patients
1,015
Services billed
5,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bimzelx AutoinjectorBimekizumab-Bkzx12$211,639
Taltz AutoinjectorIxekizumab11$74,861
Azelaic Acid156$22,340
Clobetasol Propionate347$12,156
Triamcinolone Acetonide597$7,730
Betamethasone Dipropionate105$6,801
Metronidazole85$3,452
Fluorouracil35$2,184
Cephalexin65$1,902
Doxycycline Hyclate113$1,618
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc17$1,401
Fluticasone Propionate58$1,218
Tretinoin19$1,057
Fluconazole75$1,042
MethotrexateMethotrexate Sodium18$833

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →